Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 37% ± 15% | |
| epithelial cell | 7 studies | 24% ± 6% | |
| neuron | 3 studies | 30% ± 12% | |
| endothelial cell | 3 studies | 19% ± 3% | |
| GABAergic neuron | 3 studies | 30% ± 4% | |
| glutamatergic neuron | 3 studies | 51% ± 15% | |
| goblet cell | 3 studies | 23% ± 4% | |
| astrocyte | 3 studies | 24% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 34% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 6226.70 | 2642 / 2642 | 100% | 20.35 | 702 / 705 |
| prostate | 99% | 1522.62 | 243 / 245 | 100% | 14.31 | 501 / 502 |
| kidney | 100% | 2134.26 | 89 / 89 | 98% | 16.15 | 887 / 901 |
| ovary | 100% | 1773.78 | 180 / 180 | 97% | 11.42 | 419 / 430 |
| stomach | 99% | 1494.50 | 356 / 359 | 98% | 16.80 | 281 / 286 |
| intestine | 98% | 1384.16 | 950 / 966 | 99% | 15.75 | 521 / 527 |
| esophagus | 99% | 1101.21 | 1424 / 1445 | 98% | 13.56 | 179 / 183 |
| breast | 98% | 1286.46 | 448 / 459 | 98% | 11.65 | 1100 / 1118 |
| bladder | 100% | 1356.86 | 21 / 21 | 96% | 11.90 | 483 / 504 |
| uterus | 98% | 1243.21 | 167 / 170 | 95% | 11.84 | 436 / 459 |
| thymus | 97% | 944.05 | 634 / 653 | 96% | 8.87 | 581 / 605 |
| liver | 96% | 970.08 | 216 / 226 | 95% | 9.46 | 385 / 406 |
| adrenal gland | 95% | 910.38 | 244 / 258 | 93% | 12.67 | 213 / 230 |
| skin | 96% | 1304.29 | 1734 / 1809 | 86% | 7.31 | 408 / 472 |
| lung | 79% | 637.61 | 454 / 578 | 96% | 13.47 | 1108 / 1155 |
| pancreas | 66% | 447.83 | 215 / 328 | 98% | 10.74 | 174 / 178 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.49 | 1 / 1 |
| muscle | 100% | 2429.56 | 800 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 1055.51 | 1284 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 8.29 | 43 / 45 |
| heart | 94% | 1110.71 | 813 / 861 | 0% | 0 | 0 / 0 |
| adipose | 92% | 849.21 | 1107 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 86% | 590.44 | 207 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 76% | 6.13 | 61 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.99 | 6 / 29 |
| peripheral blood | 6% | 45.39 | 55 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0006887 | Biological process | exocytosis |
| GO_1990748 | Biological process | cellular detoxification |
| GO_0009306 | Biological process | protein secretion |
| GO_0005768 | Cellular component | endosome |
| GO_0008021 | Cellular component | synaptic vesicle |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005635 | Cellular component | nuclear envelope |
| GO_0005525 | Molecular function | GTP binding |
| GO_0003924 | Molecular function | GTPase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RAB40B |
| Protein name | RAB40B, member RAS oncogene family Ras-related protein Rab-40B (SOCS box-containing protein RAR) (Protein Rar) |
| Synonyms | SEC4L |
| Description | FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. . |
| Accessions | ENST00000269347.10 ENST00000576148.1 I3L178 ENST00000538809.6 ENST00000571995.6 Q12829 J3KN64 H0YFJ5 |
